Per FDA's June 2026 warning letters, "clinically proven" language applied to compounded GLP-1 medications specifically is one of the flagged violation patterns - because the clinical trials that established GLP-1 efficacy tested FDA-approved finished products, not compounded preparations
For many patients, the challenge is not just the number on the scale it is the cycle of fatigue, reduced activity, fluid retention, and discouragement that can make healthy habits feel less effective, which is why treating thyroid disease well and considering additional weight-loss support when appropriate can both matter
However, in the presence of 20% human plasma, a 100-fold rightward curve shift was observed for the lipidated compounds, but not the conjugates and the GLP-1 analogue, indicating that MK-801 and inactive MK-801 do not associate strongly with HSA (Fig
If you are experiencing diminished results from tirzepatide and everything else in your protocol is consistent, check your vial dates first